Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$5.58 - $8.61 $1.5 Million - $2.32 Million
-269,509 Reduced 82.39%
57,624 $375,000
Q1 2024

May 14, 2024

SELL
$8.32 - $15.45 $3.75 Million - $6.96 Million
-450,266 Reduced 57.92%
327,133 $2.85 Million
Q4 2023

Feb 13, 2024

BUY
$8.79 - $11.51 $6.83 Million - $8.95 Million
777,399 New
777,399 $8.89 Million
Q3 2023

Nov 13, 2023

BUY
$8.25 - $11.35 $737,888 - $1.02 Million
89,441 Added 7.5%
1,281,269 $12.3 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $1.69 Million - $1.94 Million
167,639 Added 16.37%
1,191,828 $12.7 Million
Q1 2023

May 11, 2023

SELL
$10.37 - $12.56 $2.26 Million - $2.74 Million
-218,206 Reduced 17.56%
1,024,189 $10.8 Million
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $544,044 - $683,078
54,954 Added 4.63%
1,242,395 $15.4 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $1.31 Million - $1.6 Million
129,321 Added 12.22%
1,187,441 $12.3 Million
Q2 2022

Aug 12, 2022

BUY
$11.05 - $12.72 $4.41 Million - $5.07 Million
398,840 Added 60.5%
1,058,120 $12.2 Million
Q1 2022

May 11, 2022

BUY
$10.61 - $12.88 $855,929 - $1.04 Million
80,672 Added 13.94%
659,280 $8.29 Million
Q4 2021

Feb 07, 2022

BUY
$10.86 - $13.95 $3.07 Million - $3.95 Million
282,995 Added 95.73%
578,608 $6.75 Million
Q3 2021

Nov 10, 2021

BUY
$11.92 - $13.92 $1.22 Million - $1.42 Million
102,364 Added 52.97%
295,613 $3.86 Million
Q2 2021

Aug 05, 2021

BUY
$10.16 - $13.11 $1.06 Million - $1.37 Million
104,367 Added 117.42%
193,249 $2.49 Million
Q1 2021

May 14, 2021

SELL
$9.04 - $11.86 $218,849 - $287,118
-24,209 Reduced 21.41%
88,882 $994,000
Q4 2020

Feb 12, 2021

BUY
$9.05 - $12.2 $272,395 - $367,207
30,099 Added 36.27%
113,091 $1.29 Million
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $69,933 - $83,546
-7,779 Reduced 8.57%
82,992 $747,000
Q2 2020

Aug 13, 2020

SELL
$9.14 - $11.97 $854,507 - $1.12 Million
-93,491 Reduced 50.74%
90,771 $937,000
Q1 2020

May 14, 2020

BUY
$8.58 - $14.01 $371,994 - $607,417
43,356 Added 30.77%
184,262 $1.86 Million
Q4 2019

Feb 12, 2020

SELL
$8.22 - $14.0 $1.57 Million - $2.67 Million
-191,006 Reduced 57.55%
140,906 $1.88 Million
Q3 2019

Nov 13, 2019

BUY
$8.59 - $10.96 $362,592 - $462,632
42,211 Added 14.57%
331,912 $2.85 Million
Q2 2019

Aug 14, 2019

BUY
$9.8 - $12.89 $861,165 - $1.13 Million
87,874 Added 43.54%
289,701 $3.17 Million
Q1 2019

May 14, 2019

BUY
$8.27 - $12.73 $1.67 Million - $2.57 Million
201,827 New
201,827 $0

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.